![]() International Stem Cell Corporation International Stem Cell Corporation is a biotechnology company focused on therapeutic and research products. | ![]() Alseres Pharmaceuticals Alseres Pharmaceuticals, Inc. (ALSE) is focused on the development of diagnostic and therapeutic products for disorders in the central nervous system (CNS). | ![]() C2N Diagnostics C2N Diagnostics is a company that develops and commercializes diagnostics for Alzheimer’s disease and related forms of neurodegeneration. | |||
Founding Date | Founding Date 2021 | Founding Date 2001 | Founding Date 1972 | Founding Date 2007 | Founding Date 2002 |
Type | Type Private | Type Public | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Irvine, US HQ Los Angeles, US | Locations Carlsbad, US HQ Frederick, US Oceanside, US | Locations Newton, US HQ | Locations St. Louis, US HQ | Locations HQ |
Employees | Employees N/A | Employees 3919% decrease | Employees 4 | Employees 96 | Employees N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $9.1m (FY, 2025) | Revenue (est.) $473.7k (FY, 2013) | Revenue (est.) N/A | Revenue (est.) ₩56.2b (FY, 2023) |
Cost of goods | Cost of goods N/A | Cost of goods $4m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods ₩38.4b (FY, 2023) |
Gross profit | Gross profit N/A | Gross profit $5.1m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit ₩22.6b (FY, 2023) |
Net income | Net income N/A | Net income ($418k) (FY, 2025) | Net income ($941.5k) (FY, 2013) | Net income N/A | Net income ₩3.6b (FY, 2023) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 7.5m | Total funding raised N/A | Total funding raised $ 20m | Total funding raised N/A |

International Stem Cell Corporation is a biotechnology company focused on therapeutic and research products.
View company
Alseres Pharmaceuticals, Inc. (ALSE) is focused on the development of diagnostic and therapeutic products for disorders in the central nervous system (CNS).
View company
C2N Diagnostics is a company that develops and commercializes diagnostics for Alzheimer’s disease and related forms of neurodegeneration.
View company